As a topical , GHK-Cu usage directions may vary depending on the specific product, but in general terms, its applied directly to the target area of skin (e.g., the face in the case of acne)
LC3B has been identified as a potential biomarker and high LC3B rates can predict poor prognosis in hepatocellular carcinoma as well as colon cancer and TNBC, while p62 has also been used as a biomarker for colon cancer (240242)
It is studied for its body protection, tissue repair, and cytoprotection properties, with research focusing on its ability to support and repair bodily tissues, maintain vascular integrity, and promote healing
This product is a licensed medicine
Research involving multiple metabolic-, mitochondrial-, or stimulant-related compounds may warrant additional caution and individualized evaluation in experimental settings